An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer

NCT00570713 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: MORAb-009
DRUG: Placebo
DRUG: Gemcitabine

Sponsor

Morphotek